The American Journal of Managed Care3h
FDA Approves Obe-Cel for R/R B-Cell Acute Lymphoblastic Leukemia
Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's ...
Autolus wins FDA approval of Aucatzyl for acute lymphoblastic leukemia
FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...
The American Journal of Managed Care7h
Sunvozertinib NDA Submitted to FDA for NSCLC
A new drug application (NDA) has been submitted to the FDA for sunvozertinib in pretreated EGFR exon 20–positive advanced non ...
eLife11h
BEHAV3D Tumor Profiler to map heterogeneous cancer cell behavior in the tumor microenvironment
Tile scans were acquired using a voxel size of 0.332x0.332x1.200 µm, a pixel dwell of 2µs, and a 10% tile overlap. For 3D visualization, shift correction, object rendering, and cell tracking, ...
FierceBiotech16h
NextCure goes all in on B7-H4, stopping other programs to challenge Big Pharma in ADC space
NextCure is going all in on its preclinical B7-H4-directed antibody-drug conjugate (ADC). | NextCure is going all in on its ...